{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:02Z","timestamp":1790678042410,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Timing and onset of myocardial ischemia are mostly unpredictable. Therefore, postconditioning could be an effective cardioprotective intervention. Because ischemic postconditioning is an invasive and not practicable treatment, pharmacological postconditioning would be a more suitable alternative cardioprotective measure. For the \u03b12-adrenoreceptor agonist, dexmedetomidine postconditioning has been shown. However, data on a concentration-dependent effect of dexmedetomidine are lacking. Furthermore, it is unclear whether the time point and\/or duration of dexmedetomidine administration in the reperfusion period is of relevance. We set out to determine whether infarct size reduction by dexmedetomidine is concentration dependent and whether time point and\/or duration of dexmedetomidine application has an impact on the effect size of cardio protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Hearts of male Wistar rats were randomized and placed on a Langendorff system perfused with Krebs\u2013Henseleit buffer at a constant pressure of 80 mm Hg. All hearts were subjected to 33 minutes of global ischemia and 60 minutes of reperfusion. In part I of the study, a concentration\u2013response effect was determined by perfusing hearts with various concentrations of dexmedetomidine (0.3\u2013100 nM) at the onset of reperfusion. Based on these results, part II of the study was conducted with 3 nM dexmedetomidine. Application of dexmedetomidine started directly at the onset of reperfusion (Dex60) and 15 minutes (Dex15), 30 minutes (Dex30), or 45 minutes (Dex45) after the start of reperfusion and lasted always until the end of the reperfusion period. Infarct size was determined by triphenyltetrazolium chloride staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      In part I, infarct size in control (Con) hearts was 62% \u00b1 4%. Three-nanometer dexmedetomidine was the lowest most effective cardioprotective concentration and reduced infarct size to 24% \u00b1 7% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001 versus Con). Higher concentrations did not confer stronger protection. Infarct size in control hearts from part II was 66% \u00b1 6%. Different starting times and\/or durations of application resulted in similar infarct size reduction (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001 versus Con).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Postconditioning by dexmedetomidine is concentration dependent in ranges between 0.3 and 3 nM. Increased concentrations above 3 nM do not further enhance this cardioprotective effect. This cardioprotective effect is independent of time point and length of application in the reperfusion period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000004417","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T17:18:18Z","timestamp":1571419098000},"page":"90-98","source":"Crossref","is-referenced-by-count":33,"title":["Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia\u2013Reperfusion Injury"],"prefix":"10.1213","volume":"130","author":[{"given":"Sebastian","family":"Bunte","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Behmenburg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Majewski","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stroethoff","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Raupach","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mathes","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Heinen","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Physiology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Amsterdam Universitair Medische Centra (UMC), University of Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Huhn","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury.","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/ALN.0b013e3181fce7ea","article-title":"Hypoxia induces late preconditioning in the rat heart in vivo.","volume":"113","author":"Berger","year":"2010","journal-title":"Anesthesiology"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1871523015666160719155122","article-title":"Cardioprotection by conditioning mimetic drugs.","volume":"15","author":"Santillo","year":"2016","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ejcts.2010.11.044","article-title":"Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide.","volume":"39","author":"Caimmi","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbadis.2011.12.013","article-title":"Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia\/reperfusion injury in rat heart.","volume":"1822","author":"Ibacache","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting.","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/FJC.0000000000000466","article-title":"The cardioprotective effect of dexmedetomidine in rats is dose-dependent and mediated by BKCa channels.","volume":"69","author":"Behmenburg","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2016.12.146","article-title":"Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery.","volume":"231","author":"Cho","year":"2017","journal-title":"Int J Cardiol"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1378\/chest.11-2246","article-title":"Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery.","volume":"142","author":"Kim","year":"2012","journal-title":"Chest"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.111.255604","article-title":"Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia\/reperfusion.","volume":"109","author":"Heusch","year":"2011","journal-title":"Circ Res"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000542-200501000-00018","article-title":"Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits.","volume":"102","author":"Chiari","year":"2005","journal-title":"Anesthesiology"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2840-11-4","article-title":"Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts.","volume":"11","author":"Matsumoto","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000455815","article-title":"Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via inhibition TLR4\/MyD88\/NF-\u03baB signaling pathway.","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2152\/jmi.63.80","article-title":"Isoflurane-induced postconditioning via mitochondrial calcium-activated potassium channels.","volume":"63","author":"Kinoshita","year":"2016","journal-title":"J Med Invest"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1053\/j.jvca.2017.11.048","article-title":"Milrinone-induced postconditioning requires activation of mitochondrial Ca2+-sensitive potassium (mBKCa) channels.","volume":"32","author":"Behmenburg","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/mmr.2016.5345","article-title":"Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K\/Akt-dependent signaling pathway in reperfusion injury.","volume":"14","author":"Cheng","year":"2016","journal-title":"Mol Med Rep"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bja\/aeq213","article-title":"Ischaemic and morphine-induced post-conditioning: impact of mK(Ca) channels.","volume":"105","author":"Huhn","year":"2010","journal-title":"Br J Anaesth"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2008.07.060","article-title":"Physiological levels of glutamine prevent morphine-induced preconditioning in the isolated rat heart.","volume":"595","author":"Heinen","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"e171505","DOI":"10.1001\/jamasurg.2017.1505","article-title":"Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: a randomized clinical trial.","volume":"152","author":"Deiner","year":"2017","journal-title":"JAMA Surg"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans.","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ALN.0000000000000740","article-title":"Development of an optimized pharmacokinetic model of dexmedetomidine using target-controlled infusion in healthy volunteers.","volume":"123","author":"Hannivoort","year":"2015","journal-title":"Anesthesiology"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/joacp.JOACP_115_16","article-title":"The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: a prospective observational study.","volume":"33","author":"Kundra","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.resuscitation.2007.01.032","article-title":"The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts.","volume":"74","author":"Okada","year":"2007","journal-title":"Resuscitation"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/FJC.0000000000000600","article-title":"Melatonin receptor agonist ramelteon reduces ischemia-reperfusion injury through activation of mitochondrial potassium channels.","volume":"72","author":"Stroethoff","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00395-014-0452-7","article-title":"Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning.","volume":"110","author":"Barsukevich","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc11676","article-title":"Late pharmacologic conditioning with volatile anesthetics after cardiac surgery.","volume":"16","author":"Steurer","year":"2012","journal-title":"Crit Care"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","article-title":"Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.","volume":"47","author":"McNamara","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.CIR.66.6.1146","article-title":"The stunned myocardium: prolonged, postischemic ventricular dysfunction.","volume":"66","author":"Braunwald","year":"1982","journal-title":"Circulation"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.phrs.2015.11.004","article-title":"Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS\/NO dependent mechanism.","volume":"103","author":"Riquelme","year":"2016","journal-title":"Pharmacol Res"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10557-009-6176-5","article-title":"One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model.","volume":"23","author":"Ferrera","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"1674613","DOI":"10.1155\/2017\/1674613","article-title":"Dexmedetomidine protects cardiomyocytes against hypoxia\/reoxygenation injury by suppressing TLR4-MyD88-NF-\u03baB signaling.","volume":"2017","author":"Gao","year":"2017","journal-title":"Biomed Res Int"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/etm.2017.4537","article-title":"Dexmedetomidine attenuates hypoxia\/reoxygenation injury in primary neonatal rat cardiomyocytes.","volume":"14","author":"Peng","year":"2017","journal-title":"Exp Ther Med"},{"key":"R35-20230812","first-page":"279","article-title":"Protective effects of dexmedetomidine and remote ischemic preconditioning on renal ischemia reperfusion injury in rats.","volume":"23","author":"Balci","year":"2017","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00540-016-2214-1","article-title":"Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K\/Akt\/HIF-1\u03b1 signaling pathway.","volume":"30","author":"Zhang","year":"2016","journal-title":"J Anesth"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fncel.2017.00197","article-title":"Dexmedetomidine protects mouse brain from ischemia-reperfusion injury via inhibiting neuronal autophagy through up-regulating HIF-1\u03b1.","volume":"11","author":"Luo","year":"2017","journal-title":"Front Cell Neurosci"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:22Z","timestamp":1786112662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004417","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}